Development Timeline

2022

  • Expanded Commercial Launch

  • Developed Upper Extremity Product

  • Expanded FDA Clearance

2021

  • Full Commercial Launch 
  • Surgery being performed in the knee, shoulder, ankle, elbow and great(big) toe. 
  • Abstracts submitted for peer review publications.

2020

  • First Case in Human May 2020 
  • Post-Operative clinical data​ collection started 
  • Q3 – Controlled Market Launch (U.S. Only) 
  • Q4 – Full Market Launch​ (U.S. Only) 
  • Successful MCRA Marketing Regulatory Review 
  • New FDA Clearance “Minimally Invasive reconstruction of fractures and joints” along with additional size implants Range Now Includes 4mm-10mm 
  • FDA Clearance for the use of Hydroxyapatite Coating on all size Implants

2019

  • Final S-Core® Device Design, Manufacturing and Regulatory Validations completed
  • Thomas Kinder joins company as CEO
  • Andy Carter, Phd Biologics joins company as an advisor

2018

  • European issues Method and Device for Ameliorating Joint Conditions and Diseases Patent April 2018

2017

  • S-Core™ receives 510(k) Clearance September 2017
  • Pilot Study completed for the Bioactive S-Core™ Implant System September 2017
  • Doctor’s Brian Snyder, Eric Strauss and Marc Safran join the Scientific Advisory Board March 2017
  • U.S. issues Method and Device for Ameliorating Joint Conditions and Diseases Methods Patent issued January 2017
  • Australia issues Method and Device for Ameliorating Joint Conditions and Diseases Patent June 2017
  • Series A1 investment round closed

2016

  • Japan issues Method and Device for Amerliorating Joint – Conditions and Diseases Patent September 2016
  • Steven Arnoczky, DVM joins the Scientific Advisory Board July 2016

2015

  • Pilot Study completed for the Bio-mechanical S-Core™ Implant December 2015
  • U.S. Methods Patent issued October 2015
  • Hong Kong Issues Joint Support and Subchondral Support System Patent July 2015
  • Subchondral Solutions completes Series A financing July 2015
  • U.S. issues Method and Device for Ameliorating Joint Conditions and Diseases Patent March 2015

2014

  • U.S. issues Joint Support and Subchondral Support System – Methods Patent November 2014
  • China issues Joint Support and Subchondral Support – System Patent November 2014
  • Dr. Nathaniel Cohen joins the Scientific – Advisory Board July 2014
  • U.S. issues Joint Support and Subchondral – Support System Patent June 2014
  • Co-Founder Thay Lee, PhD Keynote Speaker for the – Athroscopy Association of America’s Annual Meeting May 2014

2013

  • John Tighe, CEO of Zipline, joins the Advisory Board
  • Subchondral Solutions, Inc. is formed. Co-Founders
  • Derek Dee, MD – Chief Medical Officer
  • Thay Lee, Phd – Chief Science Officer
  • Sheryl McCoy – Chief Financial Officer
  • Chris Maurer – Chief Technology Officer

2012

  • Singapore issues Joint Support and Subchondral Support System Patent June 2012
An error has occurred. This application may no longer respond until reloaded. Reload 🗙